A Novel Natural Compound to Target PI3K/AKT/mTOR Pathway in Pancreatic Cancer

被引：0
|
作者：
Totiger, T. [1 ]
Srinivasan, S. [1 ]
Jala, V. [2 ]
Castellanos, J. [3 ]
Lamichhane, P. [1 ]
Dai, X. [1 ]
Vansaun, M. [1 ]
Merchant, N. [1 ]
Nagathihalli, N. [1 ]
机构：
[1] Univ Miami, Dept Surg, Sylvester Comprehens Canc Ctr, Miami, FL USA
[2] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40292 USA
[3] Vanderbilt Univ, Dept Surg, Nashville, TN 37240 USA
来源：
PANCREAS | 2017年 / 46卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1440 / 1440
页数：1
相关论文
共 50 条
  • [1] Urolithin A, a Novel Natural Compound to Target PI3K/AKT/mTOR Pathway in Pancreatic Cancer
    Totiger, Tulasigeri M.
    Srinivasan, Supriya
    Jala, Venkatakrishna R.
    Lamichhane, Purushottam
    Dosch, Austin R.
    Gaidarski, Alexander A., III
    Joshi, Chandrashekhar
    Rangappa, Shobith
    Castellanos, Jason
    Vemula, Praveen Kumar
    Chen, Xi
    Kwon, Deukwoo
    Kashikar, Nilesh
    VanSaun, Michael
    Merchant, Nipun B.
    Nagathihalli, Nagaraj S.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2019, 18 (02) : 301 - 311
  • [2] PI3K/Akt/mTOR pathway as a target for cancer therapy
    Morgensztern, D
    McLeod, HL
    [J]. ANTI-CANCER DRUGS, 2005, 16 (08) : 797 - 803
  • [3] Prospects of targeting PI3K/AKT/mTOR pathway in pancreatic cancer
    Mortazavi, Motahareh
    Moosavi, Fatemeh
    Martini, Miriam
    Giovannetti, Elisa
    Firuzi, Omidreza
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 176
  • [4] The PI3K/AKT/mTOR Pathway as a Therapeutic Target in Endometrial Cancer
    Slomovitz, Brian M.
    Coleman, Robert L.
    [J]. CLINICAL CANCER RESEARCH, 2012, 18 (21) : 5856 - 5864
  • [5] The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancer
    Mabuchi, Seiji
    Kuroda, Hiromasa
    Takahashi, Ryoko
    Sasano, Tomoyuki
    [J]. GYNECOLOGIC ONCOLOGY, 2015, 137 (01) : 173 - 179
  • [6] PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer
    Li, HaiXia
    Zeng, JianFang
    Shen, Keng
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2014, 290 (06) : 1067 - 1078
  • [7] PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment
    Leiphrakpam, Premila D.
    Are, Chandrakanth
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (06)
  • [8] PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer
    HaiXia Li
    JianFang Zeng
    Keng Shen
    [J]. Archives of Gynecology and Obstetrics, 2014, 290 : 1067 - 1078
  • [9] The PI3K/Akt/mTOR Pathway as Therapeutic Target in Neuroblastoma
    Fulda, S.
    [J]. CURRENT CANCER DRUG TARGETS, 2009, 9 (06) : 729 - 737
  • [10] Activation of PI3K/Akt/mTOR Pathway and Dual Inhibitors of PI3K and mTOR in Endometrial Cancer
    Chen, Jiezhong
    Zhao, Kong-Nan
    Li, Rui
    Shao, Renfu
    Chen, Chen
    [J]. CURRENT MEDICINAL CHEMISTRY, 2014, 21 (26) : 3070 - 3080
12345